Literature DB >> 26083213

Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease.

Giovanni Monteleone, Francesco Pallone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26083213     DOI： 10.1056/NEJMc1504845

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  The Role of Neuropeptides in Mouse Models of Colitis.

Authors:  David Padua; John P Vu; Patrizia M Germano; Joseph R Pisegna
Journal:  J Mol Neurosci       Date:  2015-12-08       Impact factor: 3.444

Review 2.  Antisense technology: an overview and prospectus.

Authors:  Stanley T Crooke; Brenda F Baker; Rosanne M Crooke; Xue-Hai Liang
Journal:  Nat Rev Drug Discov       Date:  2021-03-24       Impact factor: 84.694

3.  STAT6 and Furin Are Successive Triggers for the Production of TGF-β by T Cells.

Authors:  Yue Li; Weiren Liu; Xiaqun Guan; Jamie Truscott; John W Creemers; Hung-Lin Chen; Marko Pesu; Rami G El Abiad; Bahri Karacay; Joseph F Urban; David E Elliott; Mark H Kaplan; Bruce R Blazar; M Nedim Ince
Journal:  J Immunol       Date:  2018-09-28       Impact factor: 5.422

Review 4.  Crohn's Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies.

Authors:  Ersilia M DeFilippis; Randy Longman; Michael Harbus; Kyle Dannenberg; Ellen J Scherl
Journal:  Curr Gastroenterol Rep       Date:  2016-03

5.  Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease.

Authors:  Yael Haberman; Marina BenShoshan; Ayelet Di Segni; Phillip J Dexheimer; Tzipi Braun; Batia Weiss; Thomas D Walters; Robert N Baldassano; Joshua D Noe; James Markowitz; Joel Rosh; Melvin B Heyman; Anne M Griffiths; Wallace V Crandall; David R Mack; Susan S Baker; Richard Kellermayer; Ashish Patel; Anthony Otley; Steven J Steiner; Ajay S Gulati; Stephen L Guthery; Neal LeLeiko; Dedrick Moulton; Barbara S Kirschner; Scott Snapper; Camila Avivi; Iris Barshack; Maria Oliva-Hemker; Stanley A Cohen; David J Keljo; David Ziring; Yair Anikster; Bruce Aronow; Jeffrey S Hyams; Subra Kugathasan; Lee A Denson
Journal:  Inflamm Bowel Dis       Date:  2018-01-18       Impact factor: 5.325

6.  Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal.

Authors:  Islam Khan; Sue E Samson; Ashok Kumar Grover
Journal:  Med Princ Pract       Date:  2017-03-08       Impact factor: 1.927

7.  Therapeutic oligonucleotides in cardiovascular and metabolic diseases: insights for the internist.

Authors:  Domenico Girelli; Fabiana Busti; Giacomo Marchi; Nicola Martinelli; Oliviero Olivieri
Journal:  Intern Emerg Med       Date:  2018-03-01       Impact factor: 3.397

Review 8.  Antisense technology: A review.

Authors:  Stanley T Crooke; Xue-Hai Liang; Brenda F Baker; Rosanne M Crooke
Journal:  J Biol Chem       Date:  2021-02-16       Impact factor: 5.157

Review 9.  New treatment options for inflammatory bowel diseases.

Authors:  Bram Verstockt; Marc Ferrante; Séverine Vermeire; Gert Van Assche
Journal:  J Gastroenterol       Date:  2018-03-19       Impact factor: 7.527

10.  Cytomegalovirus promotes intestinal macrophage-mediated mucosal inflammation through induction of Smad7.

Authors:  Evida A Dennis; Lesley E Smythies; Robert Grabski; Mao Li; Mary E Ballestas; Masako Shimamura; Jim J Sun; Jayleen Grams; Richard Stahl; Michael E Niederweis; William J Britt; Phillip D Smith
Journal:  Mucosal Immunol       Date:  2018-08-03       Impact factor: 7.313
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.